Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

Core Insights - Guardant Health, Inc. has successfully launched FPG 360, an in-house liquid biopsy testing service at Policlinico Gemelli in Rome, Italy [1] - This launch is part of a series of public-private partnerships that Guardant Health has established with leading European academic and research hospitals [1] Company Developments - The introduction of FPG 360 marks a significant advancement in precision oncology services offered by Guardant Health [1] - The partnership with Policlinico Gemelli highlights the company's commitment to integrating its innovative testing solutions within prominent healthcare institutions in Europe [1]